Morgan Stanley’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$398M Sell
6,223,322
-417,801
-6% -$27.5M 0.02% 673
2026
Q1
$473M Sell
6,641,123
-246,520
-4% -$19.4M 0.03% 559
2025
Q4
$565M Sell
6,887,643
-587,654
-8% -$45.8M 0.03% 489
2025
Q3
$561M Sell
7,475,297
-334,202
-4% -$24.9M 0.03% 478
2025
Q2
$578M Buy
7,809,499
+1,362,246
+21% +$94.8M 0.04% 455
2025
Q1
$520M Buy
6,447,253
+1,514,185
+31% +$130M 0.04% 452
2024
Q4
$386M Sell
4,933,068
-70,813
-1% -$6.02M 0.03% 565
2024
Q3
$470M Sell
5,003,881
-365,789
-7% -$30.7M 0.03% 493
2024
Q2
$418M Buy
5,369,670
+1,091,587
+26% +$89M 0.03% 510
2024
Q1
$389M Sell
4,278,083
-734,029
-15% -$61.1M 0.03% 530
2023
Q4
$388M Buy
5,012,112
+1,649,042
+49% +$115M 0.03% 503
2023
Q3
$229M Sell
3,363,070
-210,521
-6% -$15.3M 0.02% 639
2023
Q2
$290M Buy
3,573,591
+683,739
+24% +$54.6M 0.03% 573
2023
Q1
$237M Buy
2,889,852
+2,867,265
+12,694% +$205M 0.03% 626
2022
Q4
$1.32M Buy
+22,587
New +$1.3M ﹤0.01% 4710

Other funds holding GEHC

Morgan Stanley's GEHC Position: Q2 2026 in Review

Morgan Stanley reduced its GE HealthCare (GEHC) stake by 6.3% in Q2 2026, selling an estimated $27.5M and leaving 6,223,322 shares worth $398M. The position accounts for 0.02% of the portfolio, ranked #673.

Morgan Stanley first reported a position in GEHC in Q4 2022 and has held it in 15 quarters since. The position peaked at $578M in Q2 2025. 1,224 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Morgan Stanley held 6,223,322 shares of GE HealthCare worth $398M as of Q2 2026.
  • Morgan Stanley sold 417,801 GE HealthCare shares in Q2 2026, an estimated $27.5M.
  • GE HealthCare made up 0.02% of Morgan Stanley's portfolio in Q2 2026, its #673 holding.
  • Morgan Stanley first reported a position in GE HealthCare in Q4 2022 and has held it in 15 quarters since.
  • Morgan Stanley's GE HealthCare position peaked at $578M in Q2 2025.
  • 1,224 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.